Zobrazeno 1 - 1
of 1
pro vyhledávání: ''
Autor:
Norio Katoh, Satoshi Oizumi, Hirotoshi Dosaka-Akita, Tetsuya Inoue, Masaharu Nishimura, Ichiro Kinoshita, Hiroki Shirato, Rikiya Onimaru, Mototsugu Kato, Junko Kikuchi, Naofumi Shinagawa, Jun Sakakibara-Konishi
Publikováno v:
Lung Cancer. 74(2):248-252
Introduction Although paclitaxel with carboplatin and thoracic radiotherapy has improved survival for patients with locally advanced unresectable non-small cell lung cancer (NSCLC), the optimal dose of paclitaxel has not been well defined in Japan. T